Trade Zoetis - ZTS CFD
Add to favourite- Summary
- Historical Data
Spread | 0.27 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.026235% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004012% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 0.6 | ||||||||
Currency | USD | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 191.24 |
Open | 188.68 |
1-Year Change | 1.81% |
Day's Range | 186.53 - 189.82 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Sep 11, 2024 | 189.82 | -0.03 | -0.02% | 189.85 | 190.03 | 186.29 |
Sep 10, 2024 | 191.24 | 0.39 | 0.20% | 190.85 | 192.58 | 187.64 |
Sep 9, 2024 | 191.03 | 1.45 | 0.76% | 189.58 | 193.49 | 189.58 |
Sep 6, 2024 | 189.06 | 3.50 | 1.89% | 185.56 | 190.36 | 185.56 |
Sep 5, 2024 | 186.40 | 2.18 | 1.18% | 184.22 | 187.98 | 184.22 |
Sep 4, 2024 | 187.11 | 4.30 | 2.35% | 182.81 | 187.44 | 181.40 |
Sep 3, 2024 | 183.47 | 1.65 | 0.91% | 181.82 | 184.62 | 181.66 |
Aug 30, 2024 | 183.32 | 0.63 | 0.34% | 182.69 | 183.98 | 180.87 |
Aug 29, 2024 | 182.78 | -0.46 | -0.25% | 183.24 | 184.57 | 182.35 |
Aug 28, 2024 | 182.83 | 1.19 | 0.66% | 181.64 | 184.42 | 181.64 |
Aug 27, 2024 | 182.02 | -0.64 | -0.35% | 182.66 | 182.97 | 181.07 |
Aug 26, 2024 | 181.42 | 0.50 | 0.28% | 180.92 | 182.46 | 180.17 |
Aug 23, 2024 | 180.76 | -0.91 | -0.50% | 181.67 | 182.43 | 179.90 |
Aug 22, 2024 | 182.18 | -0.72 | -0.39% | 182.90 | 184.28 | 181.35 |
Aug 21, 2024 | 182.75 | -0.70 | -0.38% | 183.45 | 184.35 | 181.71 |
Aug 20, 2024 | 183.43 | -0.52 | -0.28% | 183.95 | 184.68 | 182.77 |
Aug 19, 2024 | 184.41 | 2.59 | 1.42% | 181.82 | 184.41 | 181.82 |
Aug 16, 2024 | 183.50 | 0.10 | 0.05% | 183.40 | 184.56 | 182.01 |
Aug 15, 2024 | 184.01 | 0.25 | 0.14% | 183.76 | 185.54 | 182.55 |
Aug 14, 2024 | 182.80 | -4.75 | -2.53% | 187.55 | 188.19 | 182.34 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Zoetis Company profile
About Zoetis Inc
Zoetis Inc. is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health technology. The Company has a business, commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, swine, poultry, fish and sheep (collectively, livestock); and within product categories such as vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. The Company operate its business through two segments: the United States and International. Within each of these operating segments, it offers a product portfolio for both companion animal and livestock customers. The Company market its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America, and its products are sold in more than 100 countries.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Zoetis Inc revenues increased 16% to $7.78B. Net income increased 24% to $2.04B. Revenues reflect International segment increase of 20% to $3.65B, US segment increase of 14% to $4.04B, United States segment increase of 14% to $4.04B, Other emerging markets segment increase of 19% to $778M. Net income benefited from Interest Expense -Gross decrease of 2% to $244M (expense).
Equity composition
Class A Common Stock $.01 Par, 2/13, 5M auth., 86,100,000 issd. Insiders own less than 1%. Class B Common Stock $.01 Par, 1B auth., 413,900,000 issd.
Industry: | Veterinary Drugs |
10 Sylvan Way
PARSIPPANY
NEW JERSEY 07054
US
News
ECB Preview: cuts expected but the pace is uncertain
Markets expect the ECB to cut rates again in September, but how many more?
12:34, 11 September 2024Market analysis: US CPI and PPI
Overview of upcoming US inflation data for August, with expectations for a year-over-year CPI drop to 2.6% and core CPI holding steady at 3.2%. Markets will also focus on U.S. PPI data, which is forecasted to show mild growth, reinforcing potential easing inflationary pressures.
07:56, 10 September 2024Introducing Newsquawk: your new in-platform newsfeed
We are very excited to announce the launch of Newsquawk in the Capital.com platform and app. This new newsfeed is designed to help you get ahead with real-time headlines, personalised stories and in-depth reports – all available directly in the platform and app, where you need them.
14:09, 20 August 2024Jackson Hole Preview: All eyes on Powell and Gold
The key focus this week will be on Jerome Powell and any insight he may give into the future of monetary policy.
15:24, 19 August 2024All eyes on inflation: US and UK CPI take centre stage
Just over a month has gone by since the latest CPI data was released in the US and so much has happened since.
14:41, 13 August 2024European stocks face resistance in their attempt to recover
European stocks struggle to recover as the tech sector faces continued downside pressure in Asia.
13:56, 9 August 2024Global selloff continues on US economy fears
Thursday’s rise in jobless claims led to a market meltdown in the US stock market as investors became concerned that the Federal Reserve made the wrong decision by keeping rates unchanged on Wednesday.
14:40, 5 August 2024People also watch
Still looking for a broker you can trust?
Join the 640,000+ traders worldwide that chose to trade with Capital.com